Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Early Stage Glycosylation Biomarkers in Alzheimer’s Disease

3 Sept 2019

Abstract excerpt

Alzheimer's disease (AD) is of great cause for concern in our ageing population, which currently lacks diagnostic tools to permit accurate and timely diagnosis for affected individuals. The development of such tools could enable therapeutic interventions earlier in the disease course and thus potentially reducing the debilitating effects of AD. Glycosylation is a common, and important, post translational...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer's disease research and treatments
Share to Glycosylation and Glycoproteins Research
Share to Lysosomal Storage Disorders Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 31484367
DOI: 10.3390/medicines6030092

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Early Stage Glycosylation Biomarkers in Alzheimer’s DiseasePMID 31484367Read ↗

Implications of Glycosylation in Alzheimer’s DiseaseSemantic proximity Read ↗

Serum N-Glycan Profiling Identifies Candidate Glycan Biomarkers for Early Detection and Prediction of Alzheimer’s DiseaseSemantic proximity Read ↗

Blood N-glycomics reveals individuals at risk for cognitive decline and Alzheimer’s diseaseSemantic proximity Read ↗

Integrative glycoproteomics reveals protein N-glycosylation aberrations and glycoproteomic network alterations in Alzheimer’s diseaseSemantic proximity Read ↗

Dessert or Poison? The Roles of Glycosylation in Alzheimer's, Parkinson's, Huntington's Disease, and Amyotrophic Lateral SclerosisSemantic proximity Read ↗

Human brain glycoform co-regulation network and glycan modification alterations in Alzheimer’s diseaseSemantic proximity Read ↗

Transcriptomic and glycomic analyses highlight pathway-specific glycosylation alterations unique to Alzheimer’s diseaseSemantic proximity Read ↗

Multilayered N-glycoproteomics reveals impaired N-glycosylation promoting Alzheimer’s diseaseSemantic proximity Read ↗

CSF N-glycoproteomics for early diagnosis in Alzheimer's diseaseSemantic proximity Read ↗

Role of Post‐translational Modifications in Alzheimer's DiseaseSemantic proximity Read ↗

Increased cerebrospinal fluid and plasma apoE glycosylation is associated with reduced levels of Alzheimer’s disease biomarkersSemantic proximity Read ↗

Simple and Fast Assay for Apolipoprotein E Phenotyping and Glycotyping: Discovering Isoform-Specific Glycosylation in Plasma and Cerebrospinal Fluid.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.